NP Life Sciences Health Industry Group Inc. (ACAT) stock
ACATOTCServices-Educational ServicesFiscal year ends December 31
Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Apr 16, 2024
$10.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $429.60MP/E –Yield –
NP Life Sciences Health Industry profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NP Life Sciences Health Industry's profit margin for the twelve months ending Dec 31, 2023 was -1.8%. For fiscal 2023 it was -1.8%, against -18.5% the year before. The highest annual figure on record is -1.8% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -1.8% | +16.7 |
| FY2022 | Dec 31, 2022 | -18.5% | +169.2 |
| FY2021 | Dec 31, 2021 | -187.7% | +686.1 |
| FY2020 | Dec 31, 2020 | -873.8% | −620.7 |
| FY2019 | Dec 31, 2019 | -253.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -153.4% | −189.5 |
| Q3 FY2023 | Sep 30, 2023 | -215.1% | −201.8 |
| Q2 FY2023 | Jun 30, 2023 | 66.5% | +59.3 |
| Q1 FY2023 | Mar 31, 2023 | 4.1% | +204.9 |
| Q4 FY2022 | Dec 31, 2022 | 36.1% | +57.6 |
| Q3 FY2022 | Sep 30, 2022 | -13.3% | +135.2 |
| Q2 FY2022 | Jun 30, 2022 | 7.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -200.8% | – |
| Q2 FY2019 | Jun 30, 2019 | -21.5% | – |
| Q1 FY2019 | Mar 31, 2019 | -148.5% | – |
See a number that looks wrong?